Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
71°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Social issues
Breaking News: Business
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Health & Science
Pharmaceuticals
Business
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Europe News
Markets
Europe Markets
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Health care industry
Investment strategy
Breaking News: Investing
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Business News
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Business News
Business
Investment Strategy
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Politics
FactSet Research Systems Inc
Goldman Sachs Group Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Economy
Paramount Global
Business News
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Daily Open
Apple Inc
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Paramount Global
Warner Bros Discovery Inc
S&P Global Inc
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Medifast Inc
Health
Health care industry
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
CNBC Changemakers
AstraZeneca PLC
Health & Science
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Novo Nordisk A/S
Healthy Returns
Health care industry
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
GSK plc
Novartis AG
Investment strategy
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Pharmaceuticals
Novo Nordisk A/S
Zealand Pharma A/S
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Employee healthcare benefits
Health care industry
Employee benefits
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Business
Health care industry
Catalent Inc
From
CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
January 31, 2024
Tags
Health & Science
Europe Markets
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Investment strategy
Business
GSK plc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
US: News
Eli Lilly and Co
Johnson & Johnson
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
JPMORGAN DRN
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Novo Nordisk A/S
Investing
Eli Lilly and Co
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Bristol/Myers Squibb Co
Pharmaceuticals
Health & Science
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
Biotech and Pharmaceuticals
Qiagen NV
Business News
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
Markets
Politics
5 Things to Know
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Weight management
Amgen Inc
Roche Holding AG
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.